Delivery Order SPE2DB22D3016-SPE2DB25FBJB6
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency awarded a delivery order valued at $8,087.53 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 200 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 40 mg/2 mL vials on August 14, 2025, with a ceiling value of $9,369.36 and firm fixed pricing. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform under this award at its corporate office location. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,809.06 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 50ML (25 units) with an ultimate completion date of September 29, 2025. This competitive award, issued on September 2, 2025, carries firm fixed pricing and involves no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.94 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine HCL 4% Solution in 4ML vials, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 50mL quantities, with a contract value of $1,076.48. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 4ML vials, with a ceiling value of $1,806.12. This firm fixed-price delivery order, issued on August 27, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is scheduled for ultimate completion by...
- This firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical on November 30, 2022. The $2,162.40 award is for the supply of 4559223224 - Lidocaine HCL 1% vials, 10mL. This order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. No...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJB6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 100 mg/5 mL vials, with a contract ceiling value of $1,097.24. The award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical vendor through its prime IDC with DLA. This delivery order represents one of numerous competitively awarded contracts through which the company supplies pharmaceutical products and medical supplies to support military and veteran healthcare systems. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to deliver an extensive range of medications, vaccines, and medical commodities to support Defense Health Agency customers and other federal healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/12/25 |